Samsung Biologics Co.,Ltd.

KSE:207940.KS

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

🔍 Research & Consulting

Location

South Korea

Market Cap

USD 52.08 B

Share Price

USD 731.75

Avg Daily Volume

82,906

Change (1 day)

-1.09%

Change (1 year)

3.77%

Change (YTD)

14.06%

Samsung Biologics Co.,Ltd. Operating Cash Flow for the year ending December 31, 2024: USD 1.12 B

Samsung Biologics Co.,Ltd. Operating Cash Flow is USD 1.12 B for the year ending December 31, 2024, a -12.74% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Samsung Biologics Co.,Ltd. Operating Cash Flow for the year ending December 31, 2023 was USD 1.28 B, a 69.96% change year over year.
Samsung Biologics Co.,Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 752.91 M, a 97.87% change year over year.
Samsung Biologics Co.,Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 380.50 M, a 105.10% change year over year.
Samsung Biologics Co.,Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 185.52 M, a 2,019.63% change year over year.